Strong Research Foundation City of Hope is a leading cancer research and treatment organization with a rich history dating back to 1913. Its extensive research capabilities and innovative breakthroughs in cancer medicines, insulin, and monoclonal antibodies position it as a key player in the healthcare innovation space.

Expanding National Network The organization has a broad and growing presence across Southern California and other major cities including Atlanta, Chicago, and Phoenix, creating multiple access points for partnership opportunities in clinical care, research, and technology integration.

Focus on Tech Innovation City of Hope actively engages with cutting-edge health tech initiatives, participating in events like HIMSS 26 and collaborating with biotech startups such as Omios Biologics, which opens avenues for digital health solutions, AI integration, and innovative treatment platforms.

Leadership in Market With an annual revenue exceeding one billion dollars and a large workforce of over 10,000 employees, City of Hope demonstrates significant financial stability and scale, making it an attractive partner for vendors offering enterprise healthcare solutions and research tools.

Recognition and Partnerships Ongoing recognition for physicians of excellence and longstanding partnerships, such as with Darvin Furniture and Appliance, reflect a community-oriented approach and a reputation that supports potential collaborations in patient engagement, wellness programs, and community health initiatives.